Know Cancer

or
forgot password

A Pilot C11-Choline PET-CT Imaging Study in Patients With Locally Advanced Esophageal Cancer


Phase 1
18 Years
N/A
Open (Enrolling)
Both
Esophageal Cancer

Thank you

Trial Information

A Pilot C11-Choline PET-CT Imaging Study in Patients With Locally Advanced Esophageal Cancer


Inclusion Criteria:



- Newly diagnosed or recurrent patients with locally advanced esophageal cancer with
either squamous or adenocarcinoma histology.

- Ability to tolerate PET imaging

- Prior malignancy is allowed, but the expectation of survival must be that beyond that
expected for patients with locally advanced esophageal cancer.

Exclusion Criteria:

- Pregnant or lactating females are not eligible for this pilot study.

- Patients having received chemotherapy in the 3 months prior to registration for any
reason

- Patients with metastatic disease requiring chemoradiation for palliation are not
allowed.

Type of Study:

Interventional

Study Design:

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Outcome Measure:

To evaluate our ability to obtain reliable and meaningful 11C-Choline PET-CT images of esophageal cancer (pre- and post- chemotherapy).

Outcome Time Frame:

2 years

Safety Issue:

No

Authority:

United States: Institutional Review Board

Study ID:

CCCWFU 60109

NCT ID:

NCT01051479

Start Date:

March 2010

Completion Date:

January 2014

Related Keywords:

  • Esophageal Cancer
  • PET Positron emission tomography
  • CT X-ray computed tomography
  • Patients with Locally Advanced Esophageal Cancer
  • Esophageal Diseases
  • Esophageal Neoplasms

Name

Location
Wake Forest University Health Sciences Winston-Salem, North Carolina  27157